Filing Details
- Accession Number:
- 0001557142-16-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-14 08:41:46
- Reporting Period:
- 2016-11-11
- Filing Date:
- 2016-11-14
- Accepted Time:
- 2016-11-14 08:41:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1557142 | Kadmon Holdings Inc. | KDMN | Pharmaceutical Preparations (2834) | 273576929 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1678736 | Konstantin Poukalov | C/O Kadmon Holdings, Inc. 450 E 29Th Street New York NY 10016 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2016-11-11 | 1,000 | $5.96 | 1,000 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2016-11-11 | 1,000 | $5.91 | 2,000 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2016-11-11 | 1,000 | $5.95 | 3,000 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2016-11-11 | 1,000 | $5.43 | 4,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |